Capecitabine Associated With Weekly Paclitaxel in Metastatic Breast Cancer.
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
Tolerance and efficacy of administration of capecitabine 5 out of 7 days associated with
weekly paclitaxel compared to the recommended treatment plan of weekly paclitaxel -
capecitabine, in patients with metastatic breast cancer.